1. Home
  2. GHM vs DSGN Comparison

GHM vs DSGN Comparison

Compare GHM & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graham Corporation

GHM

Graham Corporation

HOLD

Current Price

$66.07

Market Cap

986.4M

Sector

Industrials

ML Signal

HOLD

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$10.26

Market Cap

853.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHM
DSGN
Founded
1936
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
986.4M
853.8M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
GHM
DSGN
Price
$66.07
$10.26
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
★ $125.60
$21.71
AVG Volume (30 Days)
177.5K
★ 479.8K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 0.90
N/A
EPS
★ 0.33
N/A
Revenue
★ $245,293,000.00
N/A
Revenue This Year
$18.62
N/A
Revenue Next Year
$11.09
N/A
P/E Ratio
$195.50
★ N/A
Revenue Growth
★ 16.86
N/A
52 Week Low
$52.57
$5.73
52 Week High
$125.82
$17.25

Technical Indicators

Market Signals
Indicator
GHM
DSGN
Relative Strength Index (RSI) 25.60 35.88
Support Level N/A $9.78
Resistance Level $90.54 $11.18
Average True Range (ATR) 3.85 0.67
MACD -1.25 0.02
Stochastic Oscillator 11.73 25.33

Price Performance

Historical Comparison
GHM
DSGN

About GHM Graham Corporation

Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Share on Social Networks: